Advanced Diagnostic Equipmentsp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Advanced Diagnostic Equipment is a company that has developed a breath analysis system used in clinical studies for monitoring metabolic syndrome and measuring total cholesterol levels. They also conduct research on new materials for sensor applications, including gas sensors for NO2 detection. Additionally, they are collaborating on the commercialization of a non-invasive device called Diabetomat for diabetes management.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-04-27. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 19, 2021 | Aid for research and development projects: industrial research | $78,139 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jul 19, 2021 | Aid for research and development projects: experimental development | $53,543 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jul 19, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $25,040 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
If a one-person management board is appointed, the sole member of the management board is authorised to make declarations of will on behalf of the company and to represent it externally, independently; if a multi-member management board is appointed, the President of the Management Board independently, or two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, is authorised to make declarations of will on behalf of the company and to represent it externally.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| — | — | 0% | |
| — | — | 0% | |
Konstanty Waldemar Marszałek (73) | 340 | $9,184.22 | 0.7743% |
Artur Maciej Rydosz (41) | 340 | $9,184.22 | 0.7743% |
Others | 43,232 | $1,167,801.19 | 98.4514% |
Beneficial owners
| Person | Rights |
|---|---|
Konstanty Waldemar Marszałek (73)  | Shareholder of a limited liability company, 472200.0 PLN |
Artur Maciej Rydosz (41) | Shareholder of a limited liability company, 472200.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Dicellasp. z o.o. | $206,073.49 | dicella.com | |
| SatroecgS.A. | $117,301.57 | satroecg.pl | |
| GenomtecS.A. | $54,746.36 | genomtec.com | |
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | |
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl | |
| Solvemed Groupsp. z o.o. | $36,006.25 | solvemedgroup.com | |
| Edoktor24 Servicessp. z o.o. | $34,089.64 | edoktor24.pl | |
| Medaisp. z o.o. | $22,311.83 | medai.pl | |
| Micropurasp. z o.o. | $12,556.50 | micropura.eu | |
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl |
Change history
| Date | Event |
|---|---|
| 2025-07-05 | Share capital change (3,287,200.00 PLN → 4,391,200.00 PLN) |
| 2024-10-24 | Share capital change (2,567,200.00 PLN → 3,287,200.00 PLN) |
| 2024-10-24 | PKD change (Added: 72.19.Z) |
| 2024-04-09 | Share capital change (1,620,000.00 PLN → 2,567,200.00 PLN) |
| 2024-03-12 | Address change (Ul. Wojciecja Weissa 7/C1, 31-339, Kraków → Ul. Włodzimierza Tetmajera 79, 31-352, Kraków) |
FAQ
Last updated: 2026-07-29